CEN Biotech, Inc. (Michigan) (FITX) Announces Partnership Agreement for Dispensing Pharmacy in Michigan
February 26 2014 - 8:08AM
Access Wire
MADISON HEIGHTS, MI / February 26, 2014 /
ACCESSWIRE / Creative Edge Nutrition, Inc. (PINKSHEETS: FITX),
is proud to announce a partnership agreement with RXNB Inc. for the
first right of purchase of a pharmacy license in the State of
Michigan.
Under the agreement, CEN Biotech Inc. (A Michigan
Corporation) is positioned to establish a gateway for distribution
of naturally occurring pharmaceuticals in acknowledgement of
Michigan Senate Bill 0660.
Senate Bill 0660 recognizes the sale of
pharmaceutical-grade cannabis through licensed facilities; allowing
under certain circumstances, the regulations of possession and use
of pharmaceutical-grade cannabis by certain individuals. Effective
December 30th 2013, the bill has published as a public
law, passing both the Senate and the House successfully.
“Senate Bill 0660 is in line with our philosophy
that medicinal marijuana is a controlled substance that must be
recognized for its medicinal properties, which requires a licensed
individual & entity to dispense to the patients accordingly,
for various ailments” Bill Chaaban, CEO Creative Edge Nutrition
states.
Mr. Chaaban continues discussing alternate avenues
of dispensing, “We believe in responsible medicine and are not
opposed to alternative and or new avenues of access to
pharmaceutical-grade cannabis, but we still must recognize the
implications of the failure to provide security, traceability and
accountability”.
The agreement will allow for Creative Edge
Nutrition to conduct business at the patient dispensing consumer
level in the State of Michigan. Dr. Sam Alawieh, Pharm.D. explains
“We are excited to continue our collaboration with CEN Biotech Inc.
( Canada), CEN Biotech Inc. (Michigan), & Creative Edge
Nutrition Inc. to position ourselves in the market place to provide
patients access to medicine responsibly, pending the position of
the Federal government and pharmaceutical-cannabis’ schedule as a
controlled substance.”
“To reiterate to date, we are looking forward to
the co-operation of the many agencies required to make this a
possibility to provide a fundamentally sound and responsible avenue
for patients to have access to pharmaceutical-grade cannabis, in
uniformity of all parties engaged, patients, physicians,
municipalities, the State of Michigan and the Federal government”.
Stated CEO & President of RXNB Inc. Dr. Sam Alawieh,
Pharm.D.
RXNB Inc. currently practices patient-dispensing of
medicine and has developed an infrastructure that allots Creative
Edge Nutrition Inc. and its subsidiaries to solidify a presence in
the pharmaceutical market place.
About CEN Biotech (Canada)
CEN Biotech, Inc. was established in 2013 as a partially owned
subsidiary of Creative Edge Nutrition (OTC Pink: FITX) for the sole
purpose of supplying the Canadian public with pharmaceutical-grade
medical cannabis under the newly established Marihuana for Medical
Purposes Regulations (MMPR) CEN Biotech Inc. has submitted a
comprehensive application to become a licensed producer (LP) of
dried marihuana for medicinal purposes and has received a
ready-to-build approval from Health Canada.
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional
Supplement Company focused on developing innovative, high quality
supplements. The company offers a broad spectrum of capsules,
tablets, and powders, as well as science based products in the
principal categories of weight management, nutrition challenges,
energy and fitness. The Company manufactures under strict GMP
guidelines at GMP Certified and/or FDA registered facilities.
http://www.cenergynutrition.com/ and
https://www.facebook.com/CenergyNutrition
Safe Harbor Notice This press release may contain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995, such as statements
relating to financial results and plans for future development
activities, and are thus prospective. Forward-looking statements
include all statements that are not statements of historical fact
regarding intent, belief or current expectations of the Company,
its directors or its officers. Investors are cautioned that any
such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, many of which are
beyond the Company's ability to control. Actual results may differ
materially from those projected in the forward-looking statements.
Among the factors that could cause actual results to differ
materially from those indicated in the forward-looking statements
are risks and uncertainties associated with the Company's business
and finances in general, including the ability to continue and
manage its growth, competition, global economic conditions and
other factors discussed in detail in the Company's periodic filings
with the Security and Exchange Commission. The Company undertakes
no obligation to update any forward-looking statements.
FOR INVESTOR RELATIONS, Please Contact: William Swalm
(212) 584-4342 Email: Info@cenergynutrition.com
Source: Creative Edge Nutrition, Inc.
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Creative Edge Nutrition (CE) (USOTC:FITX)
Historical Stock Chart
From Apr 2023 to Apr 2024